nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—SLC22A11—Methotrexate—esophageal cancer	0.301	0.429	CbGbCtD
Ceftriaxone—SLC22A8—Methotrexate—esophageal cancer	0.175	0.249	CbGbCtD
Ceftriaxone—SLC22A6—Methotrexate—esophageal cancer	0.122	0.174	CbGbCtD
Ceftriaxone—ALB—Methotrexate—esophageal cancer	0.104	0.148	CbGbCtD
Ceftriaxone—GLUL—exocrine gland—esophageal cancer	0.0131	0.171	CbGeAlD
Ceftriaxone—Superinfection—Capecitabine—esophageal cancer	0.00885	0.0435	CcSEcCtD
Ceftriaxone—GLUL—neck—esophageal cancer	0.0084	0.109	CbGeAlD
Ceftriaxone—Phlebitis—Carboplatin—esophageal cancer	0.00783	0.0385	CcSEcCtD
Ceftriaxone—Alveolitis allergic—Methotrexate—esophageal cancer	0.00573	0.0282	CcSEcCtD
Ceftriaxone—GLUL—epithelium—esophageal cancer	0.00571	0.0742	CbGeAlD
Ceftriaxone—GLUL—bronchus—esophageal cancer	0.00563	0.0731	CbGeAlD
Ceftriaxone—GLUL—smooth muscle tissue—esophageal cancer	0.00551	0.0715	CbGeAlD
Ceftriaxone—Shivering—Capecitabine—esophageal cancer	0.00539	0.0265	CcSEcCtD
Ceftriaxone—GLUL—trachea—esophageal cancer	0.00505	0.0656	CbGeAlD
Ceftriaxone—Nephropathy toxic—Cisplatin—esophageal cancer	0.00475	0.0233	CcSEcCtD
Ceftriaxone—SLC15A1—epithelium—esophageal cancer	0.00472	0.0613	CbGeAlD
Ceftriaxone—SLC22A11—digestive system—esophageal cancer	0.00458	0.0595	CbGeAlD
Ceftriaxone—Serum creatinine increased—Cisplatin—esophageal cancer	0.00443	0.0218	CcSEcCtD
Ceftriaxone—GLUL—digestive system—esophageal cancer	0.00435	0.0565	CbGeAlD
Ceftriaxone—Haematocrit decreased—Methotrexate—esophageal cancer	0.00402	0.0197	CcSEcCtD
Ceftriaxone—Lymphopenia—Capecitabine—esophageal cancer	0.00393	0.0193	CcSEcCtD
Ceftriaxone—GLUL—lung—esophageal cancer	0.00363	0.0471	CbGeAlD
Ceftriaxone—SLC15A1—digestive system—esophageal cancer	0.00359	0.0467	CbGeAlD
Ceftriaxone—Infection—Carboplatin—esophageal cancer	0.00329	0.0162	CcSEcCtD
Ceftriaxone—Serum creatinine increased—Capecitabine—esophageal cancer	0.00327	0.0161	CcSEcCtD
Ceftriaxone—Tenderness—Cisplatin—esophageal cancer	0.00312	0.0154	CcSEcCtD
Ceftriaxone—SLC15A2—bronchus—esophageal cancer	0.00291	0.0378	CbGeAlD
Ceftriaxone—Pain—Carboplatin—esophageal cancer	0.00284	0.0139	CcSEcCtD
Ceftriaxone—Body temperature increased—Carboplatin—esophageal cancer	0.00262	0.0129	CcSEcCtD
Ceftriaxone—SLC15A2—trachea—esophageal cancer	0.00261	0.0339	CbGeAlD
Ceftriaxone—Fungal infection—Capecitabine—esophageal cancer	0.0026	0.0128	CcSEcCtD
Ceftriaxone—Coagulopathy—Capecitabine—esophageal cancer	0.00258	0.0127	CcSEcCtD
Ceftriaxone—GLUL—lymph node—esophageal cancer	0.00248	0.0322	CbGeAlD
Ceftriaxone—Phlebitis—Cisplatin—esophageal cancer	0.0023	0.0113	CcSEcCtD
Ceftriaxone—Proteinuria—Capecitabine—esophageal cancer	0.00229	0.0112	CcSEcCtD
Ceftriaxone—Protein urine present—Capecitabine—esophageal cancer	0.00226	0.0111	CcSEcCtD
Ceftriaxone—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00219	0.0108	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00204	0.0101	CcSEcCtD
Ceftriaxone—Fungal infection—Methotrexate—esophageal cancer	0.00194	0.00952	CcSEcCtD
Ceftriaxone—Colitis—Capecitabine—esophageal cancer	0.00193	0.00948	CcSEcCtD
Ceftriaxone—Candida infection—Capecitabine—esophageal cancer	0.00192	0.00943	CcSEcCtD
Ceftriaxone—SLC15A2—lung—esophageal cancer	0.00188	0.0244	CbGeAlD
Ceftriaxone—Blood creatinine increased—Cisplatin—esophageal cancer	0.00185	0.00911	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00178	0.00876	CcSEcCtD
Ceftriaxone—Proteinuria—Methotrexate—esophageal cancer	0.0017	0.00837	CcSEcCtD
Ceftriaxone—Phlebitis—Capecitabine—esophageal cancer	0.00169	0.00832	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Capecitabine—esophageal cancer	0.00169	0.00828	CcSEcCtD
Ceftriaxone—Protein urine present—Methotrexate—esophageal cancer	0.00168	0.00825	CcSEcCtD
Ceftriaxone—Pancreatitis—Cisplatin—esophageal cancer	0.00168	0.00824	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00167	0.0082	CcSEcCtD
Ceftriaxone—Sweating increased—Cisplatin—esophageal cancer	0.00167	0.00819	CcSEcCtD
Ceftriaxone—Oliguria—Methotrexate—esophageal cancer	0.00162	0.00798	CcSEcCtD
Ceftriaxone—Glossitis—Methotrexate—esophageal cancer	0.00162	0.00798	CcSEcCtD
Ceftriaxone—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00162	0.00794	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00155	0.0076	CcSEcCtD
Ceftriaxone—ALB—lymph node—esophageal cancer	0.00154	0.02	CbGeAlD
Ceftriaxone—Renal impairment—Capecitabine—esophageal cancer	0.00153	0.00753	CcSEcCtD
Ceftriaxone—Renal failure—Cisplatin—esophageal cancer	0.0015	0.00737	CcSEcCtD
Ceftriaxone—Vaginal inflammation—Methotrexate—esophageal cancer	0.0015	0.00735	CcSEcCtD
Ceftriaxone—Stomatitis—Cisplatin—esophageal cancer	0.00149	0.00731	CcSEcCtD
Ceftriaxone—Vaginal infection—Methotrexate—esophageal cancer	0.00141	0.00694	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Methotrexate—esophageal cancer	0.0014	0.0069	CcSEcCtD
Ceftriaxone—Ataxia—Capecitabine—esophageal cancer	0.00137	0.00674	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Capecitabine—esophageal cancer	0.00137	0.00672	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Capecitabine—esophageal cancer	0.00133	0.00655	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00131	0.00646	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00131	0.00646	CcSEcCtD
Ceftriaxone—SLC15A2—lymph node—esophageal cancer	0.00128	0.0167	CbGeAlD
Ceftriaxone—Flushing—Cisplatin—esophageal cancer	0.00127	0.00625	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Methotrexate—esophageal cancer	0.00125	0.00617	CcSEcCtD
Ceftriaxone—Bronchospasm—Capecitabine—esophageal cancer	0.00124	0.0061	CcSEcCtD
Ceftriaxone—Sweating increased—Capecitabine—esophageal cancer	0.00123	0.00604	CcSEcCtD
Ceftriaxone—Neutropenia—Capecitabine—esophageal cancer	0.00118	0.0058	CcSEcCtD
Ceftriaxone—Flatulence—Cisplatin—esophageal cancer	0.00117	0.00577	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00115	0.00566	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00112	0.00552	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00111	0.00548	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Cisplatin—esophageal cancer	0.00111	0.00544	CcSEcCtD
Ceftriaxone—Renal failure—Capecitabine—esophageal cancer	0.0011	0.00543	CcSEcCtD
Ceftriaxone—Anaemia—Cisplatin—esophageal cancer	0.0011	0.00541	CcSEcCtD
Ceftriaxone—Stomatitis—Capecitabine—esophageal cancer	0.0011	0.00539	CcSEcCtD
Ceftriaxone—Jaundice—Capecitabine—esophageal cancer	0.0011	0.00539	CcSEcCtD
Ceftriaxone—Malaise—Cisplatin—esophageal cancer	0.00107	0.00528	CcSEcCtD
Ceftriaxone—Haematuria—Capecitabine—esophageal cancer	0.00107	0.00527	CcSEcCtD
Ceftriaxone—Leukopenia—Cisplatin—esophageal cancer	0.00107	0.00524	CcSEcCtD
Ceftriaxone—Epistaxis—Capecitabine—esophageal cancer	0.00106	0.00521	CcSEcCtD
Ceftriaxone—Agranulocytosis—Capecitabine—esophageal cancer	0.00105	0.00516	CcSEcCtD
Ceftriaxone—Convulsion—Cisplatin—esophageal cancer	0.00103	0.00508	CcSEcCtD
Ceftriaxone—Ataxia—Methotrexate—esophageal cancer	0.00102	0.00502	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—MAP3K3—esophageal cancer	0.00102	0.0582	CbGpPWpGaD
Ceftriaxone—Haemoglobin—Capecitabine—esophageal cancer	0.00101	0.00499	CcSEcCtD
Ceftriaxone—Haemorrhage—Capecitabine—esophageal cancer	0.00101	0.00496	CcSEcCtD
Ceftriaxone—Discomfort—Cisplatin—esophageal cancer	0.001	0.00493	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000978	0.00481	CcSEcCtD
Ceftriaxone—Oedema—Cisplatin—esophageal cancer	0.000973	0.00478	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Cisplatin—esophageal cancer	0.000973	0.00478	CcSEcCtD
Ceftriaxone—Infection—Cisplatin—esophageal cancer	0.000966	0.00475	CcSEcCtD
Ceftriaxone—Erythema multiforme—Capecitabine—esophageal cancer	0.000954	0.00469	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Cisplatin—esophageal cancer	0.000952	0.00468	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Cisplatin—esophageal cancer	0.00094	0.00462	CcSEcCtD
Ceftriaxone—Flushing—Capecitabine—esophageal cancer	0.000937	0.0046	CcSEcCtD
Ceftriaxone—Eosinophilia—Methotrexate—esophageal cancer	0.000929	0.00457	CcSEcCtD
Ceftriaxone—Pancreatitis—Methotrexate—esophageal cancer	0.00092	0.00452	CcSEcCtD
Ceftriaxone—Chills—Capecitabine—esophageal cancer	0.000905	0.00445	CcSEcCtD
Ceftriaxone—Neutropenia—Methotrexate—esophageal cancer	0.000878	0.00431	CcSEcCtD
Ceftriaxone—Paraesthesia—Cisplatin—esophageal cancer	0.000873	0.00429	CcSEcCtD
Ceftriaxone—Flatulence—Capecitabine—esophageal cancer	0.000866	0.00426	CcSEcCtD
Ceftriaxone—Dysgeusia—Capecitabine—esophageal cancer	0.00086	0.00423	CcSEcCtD
Ceftriaxone—Pain—Cisplatin—esophageal cancer	0.000832	0.00409	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00083	0.00408	CcSEcCtD
Ceftriaxone—Renal failure—Methotrexate—esophageal cancer	0.000823	0.00404	CcSEcCtD
Ceftriaxone—Stomatitis—Methotrexate—esophageal cancer	0.000816	0.00401	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Capecitabine—esophageal cancer	0.000815	0.00401	CcSEcCtD
Ceftriaxone—Anaemia—Capecitabine—esophageal cancer	0.000812	0.00399	CcSEcCtD
Ceftriaxone—Feeling abnormal—Cisplatin—esophageal cancer	0.000801	0.00394	CcSEcCtD
Ceftriaxone—Haematuria—Methotrexate—esophageal cancer	0.000798	0.00392	CcSEcCtD
Ceftriaxone—Malaise—Capecitabine—esophageal cancer	0.000792	0.00389	CcSEcCtD
Ceftriaxone—Epistaxis—Methotrexate—esophageal cancer	0.000789	0.00388	CcSEcCtD
Ceftriaxone—Leukopenia—Capecitabine—esophageal cancer	0.000786	0.00387	CcSEcCtD
Ceftriaxone—Agranulocytosis—Methotrexate—esophageal cancer	0.000781	0.00384	CcSEcCtD
Ceftriaxone—Palpitations—Capecitabine—esophageal cancer	0.000776	0.00382	CcSEcCtD
Ceftriaxone—Body temperature increased—Cisplatin—esophageal cancer	0.000769	0.00378	CcSEcCtD
Ceftriaxone—Haemoglobin—Methotrexate—esophageal cancer	0.000755	0.00371	CcSEcCtD
Ceftriaxone—Haemorrhage—Methotrexate—esophageal cancer	0.000751	0.00369	CcSEcCtD
Ceftriaxone—Discomfort—Capecitabine—esophageal cancer	0.000739	0.00363	CcSEcCtD
Ceftriaxone—ALB—Recycling of bile acids and salts—SLC10A2—esophageal cancer	0.000722	0.0413	CbGpPWpGaD
Ceftriaxone—Oedema—Capecitabine—esophageal cancer	0.000717	0.00352	CcSEcCtD
Ceftriaxone—Hypersensitivity—Cisplatin—esophageal cancer	0.000717	0.00352	CcSEcCtD
Ceftriaxone—Infection—Capecitabine—esophageal cancer	0.000712	0.0035	CcSEcCtD
Ceftriaxone—Erythema multiforme—Methotrexate—esophageal cancer	0.00071	0.00349	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Capecitabine—esophageal cancer	0.000702	0.00345	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Capecitabine—esophageal cancer	0.000693	0.00341	CcSEcCtD
Ceftriaxone—Chills—Methotrexate—esophageal cancer	0.000674	0.00331	CcSEcCtD
Ceftriaxone—Diarrhoea—Cisplatin—esophageal cancer	0.000665	0.00327	CcSEcCtD
Ceftriaxone—Paraesthesia—Capecitabine—esophageal cancer	0.000644	0.00316	CcSEcCtD
Ceftriaxone—Dysgeusia—Methotrexate—esophageal cancer	0.00064	0.00315	CcSEcCtD
Ceftriaxone—Dyspepsia—Capecitabine—esophageal cancer	0.000631	0.0031	CcSEcCtD
Ceftriaxone—Vomiting—Cisplatin—esophageal cancer	0.000618	0.00304	CcSEcCtD
Ceftriaxone—Rash—Cisplatin—esophageal cancer	0.000613	0.00301	CcSEcCtD
Ceftriaxone—Pain—Capecitabine—esophageal cancer	0.000613	0.00301	CcSEcCtD
Ceftriaxone—Dermatitis—Cisplatin—esophageal cancer	0.000613	0.00301	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Methotrexate—esophageal cancer	0.000607	0.00298	CcSEcCtD
Ceftriaxone—Anaemia—Methotrexate—esophageal cancer	0.000604	0.00297	CcSEcCtD
Ceftriaxone—Feeling abnormal—Capecitabine—esophageal cancer	0.000591	0.0029	CcSEcCtD
Ceftriaxone—Malaise—Methotrexate—esophageal cancer	0.00059	0.0029	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000586	0.00288	CcSEcCtD
Ceftriaxone—Leukopenia—Methotrexate—esophageal cancer	0.000585	0.00288	CcSEcCtD
Ceftriaxone—Nausea—Cisplatin—esophageal cancer	0.000578	0.00284	CcSEcCtD
Ceftriaxone—Urticaria—Capecitabine—esophageal cancer	0.00057	0.0028	CcSEcCtD
Ceftriaxone—Abdominal pain—Capecitabine—esophageal cancer	0.000567	0.00279	CcSEcCtD
Ceftriaxone—Body temperature increased—Capecitabine—esophageal cancer	0.000567	0.00279	CcSEcCtD
Ceftriaxone—Convulsion—Methotrexate—esophageal cancer	0.000567	0.00279	CcSEcCtD
Ceftriaxone—Discomfort—Methotrexate—esophageal cancer	0.00055	0.0027	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Methotrexate—esophageal cancer	0.000534	0.00262	CcSEcCtD
Ceftriaxone—Infection—Methotrexate—esophageal cancer	0.00053	0.00261	CcSEcCtD
Ceftriaxone—Hypersensitivity—Capecitabine—esophageal cancer	0.000528	0.0026	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Methotrexate—esophageal cancer	0.000523	0.00257	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Methotrexate—esophageal cancer	0.000516	0.00254	CcSEcCtD
Ceftriaxone—Pruritus—Capecitabine—esophageal cancer	0.000507	0.00249	CcSEcCtD
Ceftriaxone—Diarrhoea—Capecitabine—esophageal cancer	0.000491	0.00241	CcSEcCtD
Ceftriaxone—Paraesthesia—Methotrexate—esophageal cancer	0.000479	0.00236	CcSEcCtD
Ceftriaxone—Dizziness—Capecitabine—esophageal cancer	0.000474	0.00233	CcSEcCtD
Ceftriaxone—Dyspepsia—Methotrexate—esophageal cancer	0.00047	0.00231	CcSEcCtD
Ceftriaxone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00046	0.0263	CbGpPWpGaD
Ceftriaxone—Pain—Methotrexate—esophageal cancer	0.000456	0.00224	CcSEcCtD
Ceftriaxone—Vomiting—Capecitabine—esophageal cancer	0.000456	0.00224	CcSEcCtD
Ceftriaxone—Rash—Capecitabine—esophageal cancer	0.000452	0.00222	CcSEcCtD
Ceftriaxone—Dermatitis—Capecitabine—esophageal cancer	0.000452	0.00222	CcSEcCtD
Ceftriaxone—Headache—Capecitabine—esophageal cancer	0.000449	0.00221	CcSEcCtD
Ceftriaxone—Feeling abnormal—Methotrexate—esophageal cancer	0.00044	0.00216	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000436	0.00215	CcSEcCtD
Ceftriaxone—Nausea—Capecitabine—esophageal cancer	0.000426	0.00209	CcSEcCtD
Ceftriaxone—Urticaria—Methotrexate—esophageal cancer	0.000424	0.00208	CcSEcCtD
Ceftriaxone—Body temperature increased—Methotrexate—esophageal cancer	0.000422	0.00207	CcSEcCtD
Ceftriaxone—Abdominal pain—Methotrexate—esophageal cancer	0.000422	0.00207	CcSEcCtD
Ceftriaxone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000421	0.0241	CbGpPWpGaD
Ceftriaxone—Hypersensitivity—Methotrexate—esophageal cancer	0.000393	0.00193	CcSEcCtD
Ceftriaxone—Pruritus—Methotrexate—esophageal cancer	0.000378	0.00186	CcSEcCtD
Ceftriaxone—ALB—Bile acid and bile salt metabolism—SLC10A2—esophageal cancer	0.000378	0.0216	CbGpPWpGaD
Ceftriaxone—Diarrhoea—Methotrexate—esophageal cancer	0.000365	0.0018	CcSEcCtD
Ceftriaxone—Dizziness—Methotrexate—esophageal cancer	0.000353	0.00173	CcSEcCtD
Ceftriaxone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000351	0.0201	CbGpPWpGaD
Ceftriaxone—Vomiting—Methotrexate—esophageal cancer	0.000339	0.00167	CcSEcCtD
Ceftriaxone—Rash—Methotrexate—esophageal cancer	0.000337	0.00165	CcSEcCtD
Ceftriaxone—Dermatitis—Methotrexate—esophageal cancer	0.000336	0.00165	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—BAX—esophageal cancer	0.000335	0.0192	CbGpPWpGaD
Ceftriaxone—Headache—Methotrexate—esophageal cancer	0.000334	0.00164	CcSEcCtD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000326	0.0186	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000321	0.0184	CbGpPWpGaD
Ceftriaxone—Nausea—Methotrexate—esophageal cancer	0.000317	0.00156	CcSEcCtD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000305	0.0175	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.000293	0.0168	CbGpPWpGaD
Ceftriaxone—GLUL—Amino acid and derivative metabolism—PSME2—esophageal cancer	0.000282	0.0161	CbGpPWpGaD
Ceftriaxone—GLUL—Amino acid and derivative metabolism—PSME1—esophageal cancer	0.000282	0.0161	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000268	0.0153	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—GNG7—esophageal cancer	0.00025	0.0143	CbGpPWpGaD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—CASP8—esophageal cancer	0.000238	0.0136	CbGpPWpGaD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—CREBBP—esophageal cancer	0.000237	0.0136	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—ALDH2—esophageal cancer	0.000234	0.0134	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000209	0.012	CbGpPWpGaD
Ceftriaxone—ALB—FOXA2 and FOXA3 transcription factor networks—ALDOB—esophageal cancer	0.000199	0.0114	CbGpPWpGaD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000193	0.0111	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000191	0.0109	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—PRDX2—esophageal cancer	0.000185	0.0106	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—PRDX1—esophageal cancer	0.000185	0.0106	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000179	0.0103	CbGpPWpGaD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000177	0.0101	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000164	0.00938	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000159	0.00913	CbGpPWpGaD
Ceftriaxone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CALR—esophageal cancer	0.000151	0.00862	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—PFN1—esophageal cancer	0.000146	0.00837	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000146	0.00835	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—esophageal cancer	0.000139	0.00797	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000133	0.00762	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—BLVRB—esophageal cancer	0.000132	0.00755	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—SLC52A3—esophageal cancer	0.000132	0.00755	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000122	0.00697	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000119	0.00682	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—CFL1—esophageal cancer	0.000119	0.00678	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—CFL1—esophageal cancer	0.000113	0.00646	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CA1—esophageal cancer	0.000112	0.00642	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—SLC10A2—esophageal cancer	0.000112	0.00642	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000112	0.00641	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00011	0.0063	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000106	0.00608	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000104	0.00593	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CA2—esophageal cancer	0.000103	0.00587	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000102	0.00585	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000101	0.0058	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	9.82e-05	0.00562	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ATP4A—esophageal cancer	9.72e-05	0.00556	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	9.72e-05	0.00556	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	9.61e-05	0.0055	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PLCE1—esophageal cancer	9.53e-05	0.00546	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ADH7—esophageal cancer	9.53e-05	0.00546	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—AQP3—esophageal cancer	9.37e-05	0.00536	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—SOD2—esophageal cancer	9.13e-05	0.00522	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	9.11e-05	0.00521	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—HSPA5—esophageal cancer	9.11e-05	0.00521	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	9.09e-05	0.0052	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.98e-05	0.00514	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.98e-05	0.00514	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	8.69e-05	0.00497	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—esophageal cancer	8.68e-05	0.00496	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—PTGS1—esophageal cancer	8.65e-05	0.00495	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	8.55e-05	0.00489	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ADH1B—esophageal cancer	8.36e-05	0.00478	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.33e-05	0.00477	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.33e-05	0.00477	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	8.1e-05	0.00464	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—TYMP—esophageal cancer	7.99e-05	0.00457	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CYP26A1—esophageal cancer	7.77e-05	0.00445	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—AQP3—esophageal cancer	7.73e-05	0.00442	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	7.59e-05	0.00434	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALOX15—esophageal cancer	7.57e-05	0.00433	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—SOD2—esophageal cancer	7.43e-05	0.00425	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ATP4A—esophageal cancer	7.41e-05	0.00424	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	7.41e-05	0.00424	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ABCC2—esophageal cancer	7.37e-05	0.00421	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—TPI1—esophageal cancer	7.23e-05	0.00413	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GSTO1—esophageal cancer	7.23e-05	0.00413	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	7.14e-05	0.00408	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALDOB—esophageal cancer	6.93e-05	0.00396	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	6.92e-05	0.00396	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.81e-05	0.00389	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	6.76e-05	0.00387	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.68e-05	0.00382	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GAPDH—esophageal cancer	6.67e-05	0.00382	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CRABP1—esophageal cancer	6.61e-05	0.00378	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PFN1—esophageal cancer	6.49e-05	0.00371	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CAPZA1—esophageal cancer	6.47e-05	0.0037	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	6.45e-05	0.00369	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	6.33e-05	0.00362	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.32e-05	0.00361	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GNG7—esophageal cancer	6.29e-05	0.0036	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	6.19e-05	0.00354	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	6.19e-05	0.00354	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.18e-05	0.00353	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—SOD2—esophageal cancer	5.9e-05	0.00338	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALDH2—esophageal cancer	5.89e-05	0.00337	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.73e-05	0.00328	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ABCC2—esophageal cancer	5.62e-05	0.00321	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GSTT1—esophageal cancer	5.6e-05	0.00321	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CYP2A6—esophageal cancer	5.54e-05	0.00317	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—CFL1—esophageal cancer	5.26e-05	0.00301	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ENO1—esophageal cancer	5.25e-05	0.003	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTGS1—esophageal cancer	5.25e-05	0.003	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PSME1—esophageal cancer	5.17e-05	0.00296	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PSME2—esophageal cancer	5.17e-05	0.00296	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.1e-05	0.00292	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—GNG7—esophageal cancer	4.96e-05	0.00284	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	4.69e-05	0.00268	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CYP1B1—esophageal cancer	4.46e-05	0.00255	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ATP1B2—esophageal cancer	4.28e-05	0.00245	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.25e-05	0.00243	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CYP19A1—esophageal cancer	4.2e-05	0.0024	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	4.15e-05	0.00237	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.07e-05	0.00233	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	4.04e-05	0.00231	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	3.94e-05	0.00226	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.91e-05	0.00224	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—DOCK2—esophageal cancer	3.87e-05	0.00222	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—HMOX1—esophageal cancer	3.83e-05	0.00219	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.76e-05	0.00215	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	3.71e-05	0.00212	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ABCB1—esophageal cancer	3.68e-05	0.0021	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.61e-05	0.00207	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	3.52e-05	0.00201	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.49e-05	0.002	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—AQP3—esophageal cancer	3.35e-05	0.00192	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.35e-05	0.00192	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PFN1—esophageal cancer	3.34e-05	0.00191	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—PTGS2—esophageal cancer	3.31e-05	0.0019	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ATP4A—esophageal cancer	3.22e-05	0.00184	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	3.22e-05	0.00184	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.11e-05	0.00178	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.98e-05	0.00171	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	2.8e-05	0.0016	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CFL1—esophageal cancer	2.71e-05	0.00155	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.61e-05	0.00149	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.59e-05	0.00148	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—GNG7—esophageal cancer	2.55e-05	0.00146	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.49e-05	0.00142	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TP53—esophageal cancer	2.48e-05	0.00142	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CREBBP—esophageal cancer	2.46e-05	0.00141	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.45e-05	0.0014	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	2.44e-05	0.00139	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.41e-05	0.00138	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.24e-05	0.00128	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.21e-05	0.00127	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—NOS3—esophageal cancer	2.2e-05	0.00126	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC52A3—esophageal cancer	2.17e-05	0.00124	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—BLVRB—esophageal cancer	2.17e-05	0.00124	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—HSPA5—esophageal cancer	2.08e-05	0.00119	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTGS2—esophageal cancer	2.01e-05	0.00115	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.99e-05	0.00114	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.94e-05	0.00111	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CA1—esophageal cancer	1.85e-05	0.00106	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SLC10A2—esophageal cancer	1.85e-05	0.00106	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CA2—esophageal cancer	1.69e-05	0.000967	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—EP300—esophageal cancer	1.67e-05	0.000957	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.66e-05	0.000951	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.65e-05	0.000945	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLCE1—esophageal cancer	1.57e-05	0.000899	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ADH7—esophageal cancer	1.57e-05	0.000899	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.55e-05	0.000889	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ABL1—esophageal cancer	1.54e-05	0.000883	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ADH1B—esophageal cancer	1.38e-05	0.000788	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.35e-05	0.000771	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—TYMP—esophageal cancer	1.32e-05	0.000753	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.29e-05	0.00074	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP26A1—esophageal cancer	1.28e-05	0.000733	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALOX15—esophageal cancer	1.25e-05	0.000714	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CA—esophageal cancer	1.24e-05	0.000708	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—TPI1—esophageal cancer	1.19e-05	0.000681	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTO1—esophageal cancer	1.19e-05	0.000681	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDOB—esophageal cancer	1.14e-05	0.000653	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS2—esophageal cancer	1.11e-05	0.000636	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GAPDH—esophageal cancer	1.1e-05	0.000629	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CRABP1—esophageal cancer	1.09e-05	0.000623	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GNG7—esophageal cancer	1.04e-05	0.000593	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CREBBP—esophageal cancer	9.98e-06	0.000571	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	9.76e-06	0.000558	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDH2—esophageal cancer	9.71e-06	0.000555	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTT1—esophageal cancer	9.23e-06	0.000528	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP2A6—esophageal cancer	9.13e-06	0.000522	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.09e-06	0.00052	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS3—esophageal cancer	8.94e-06	0.000512	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGS1—esophageal cancer	8.65e-06	0.000495	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ENO1—esophageal cancer	8.65e-06	0.000495	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.64e-06	0.000495	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PSME2—esophageal cancer	8.52e-06	0.000488	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PSME1—esophageal cancer	8.52e-06	0.000488	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.44e-06	0.000426	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP1B1—esophageal cancer	7.36e-06	0.000421	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP19A1—esophageal cancer	6.92e-06	0.000396	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—EP300—esophageal cancer	6.8e-06	0.000389	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMOX1—esophageal cancer	6.31e-06	0.000361	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.19e-06	0.000354	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCB1—esophageal cancer	6.06e-06	0.000347	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CA—esophageal cancer	5.03e-06	0.000288	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TP53—esophageal cancer	4.87e-06	0.000278	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.58e-06	0.000262	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CREBBP—esophageal cancer	4.05e-06	0.000232	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NOS3—esophageal cancer	3.62e-06	0.000207	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGS2—esophageal cancer	3.32e-06	0.00019	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—EP300—esophageal cancer	2.76e-06	0.000158	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CA—esophageal cancer	2.04e-06	0.000117	CbGpPWpGaD
